Inhibitory Effects of Soyeum Pharmacopuncture (SPP) on Rheumatoid Arthritis in Collagen II-induced Arthritis (CIA) Mice

소염약침액이 Collagen II 유발 관절염 mouse의 TNF-α, IFN-γ 생성 및 비장세포 증식에 미치는 영향

  • Yoo, Hwa-Seung (East-West Cancer Center, College of Oriental Medicine, Daejeon University) ;
  • Youn, Dae-Hwan (Department of Meridian and Acupoint, College of Oriental Medicine, Dongshin University) ;
  • Kim, Seung-Hyung (Institute of Traditional Medicine and Bioscience, Daejeon University) ;
  • Lim, Jong-Soon (Institute of Traditional Medicine and Bioscience, Daejeon University)
  • 유화승 (대전대학교 한의과대학 동서암센터) ;
  • 윤대환 (동신대학교 한의과대학 경혈학교실) ;
  • 김승형 (대전대학교 동서생명과학연구원) ;
  • 임종순 (대전대학교 동서생명과학연구원)
  • Published : 2007.06.30


Objective : The aim is to examine the effect of Soyeum Pharmacopuncture (SPP) on collagen-induced arthritis (CIA) in DBA/1OlaHsd mice. Methods : To determine the effect of SPP on chronic IFNlammatory joint disease, we induced CIA in DBA/1OlaHsd mice by immunization with bovine type II collagen. Animals were treated with intraperitoneal injection doses of 2 mg/kg of SPP, beginning 3 days before the expected onset of disease symptoms. Inhibitory Effects of SPP were observed by serum levels of TNF-${\alpha}$, and IFN-${\gamma}$,,, or cell proliferation in the spleen cell culture and histological examination of knee joint. Results : In the CIA Mice, serum levels of TNF-${\alpha}$, and IFN-${\gamma}$,, production in the spleen cell culture were reduced. At the histopathological examination of knee joint, chondropathy of cartilage in the synovial joint in the SP group was repaired while compared with control group. Conclusion : These results suggest that the SPP may be effective for the prevention and treatment of rheumatoid arthritis disease.


  1. Maini RN, Zvaifler NJ. Rheumatoid arthritis and spondyloarthropathy. Rhematology P.3.3.2, London, Mosby, 1994
  2. Gary S. Firestein. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361, 2003
  3. Carson DA, Chen PP, Kipps TJ. New roles for rheumatoid factor. J Clin Invest 87: 379-383, 1991
  4. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2(6): 473-488, 2003
  5. Aletaha D, Smolen JS. DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease. Clin Exp Rheumatol Sep-Oct; 21(5 Suppl 31): S169-S173, 2003
  6. Ten Wolde S, Breedveld FC, Hermans J, Vandenbroucke JP, van de Laar MA, Markusse HM, Janssen M, van den Brink HR, Dijkmans BA. Randomised placebo-controlled study of stopping secondline drugs in rheumatoid arthritis. Lancet 10; 347 (8998): 347-352, 1996
  7. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19: 163-196, 2001
  8. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 358: 903-911, 2001
  9. 김병수 : 玄胡索. 赤芍藥. 紅花 混合藥鍼液이 關節炎 白鼠의 炎症과 肝에 미치는 影響, 경원대학교 석사학위논문, 2004
  10. 서형식. 소염약침액이 staphylococcus aureus와 staphylococcus epidermidis에 미치는 항균효과에 대한 실험적 연구. 대한약침학회지, 9(2):73-77, 2006
  11. Oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F.H. Chen. Chem Pharm Bull 45 : 1039-1045, 1997
  12. Kim DS, Chang YJ, Zedk U, Zhao P, Liu YQ, Yang CR. Dammarane saponins from Panax ginseng. Phytochemistry 40(5): 1493-1497, 1995
  13. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26(2): 171-176, 1980
  14. Lenardo MJ, et al. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature. 353(6347): 858-861, 1991
  15. Iwai H, Kozono Y, Hirose S, Akiba H, Yagita H, Okumura K, Kohsaka H, Miyasaka N, Azuma M. Amelioration of collagen-induced arthritis by blocade of inducible costimulator-B7 homologous protein costimulation. J of Immunol 169: 4332-4339, 2002
  16. Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol 1985 ; 12 : 35-9
  17. Bradley, D. S.; Nabozny, G. H.; Cheng, S.; Zhou, P.; Griffiths, M. M.; Luthra, H. S.; David, C. S. : HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice: implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234, 1997
  18. 서울대학교 의과대학. 면역학. 서울 : 서울대학교 출판부. 1982 : 1-25, 229-46
  19. Tighe H, Chen PP, Tucker R, et al. Function of B cells expressing a human immunoglobulin M rhematoid factor autoantibody in transgenic mice. J Exp Med 177: 109-118, 1993
  20. Simon LS. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Int J Clin Pract 54: 243-249, 2000
  21. 이진훈 : 계혈등의 항염활성효과, 강원대학교 석사학위논문, 1999
  22. 조영주 : 희첨이 炎症性 사이토카인 및 류마티스양 關節炎에 미치는 影響, 대전대학교 박사학위논문, 2003
  23. 서형식. 소염약침액, 황련해독탕, 황련이 staphylococcus aureus에 미치는 항균효과에 대한 실험적 연구. 대한약침학회지, 9(2):87-92, 2006
  24. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397-440, 1996
  25. American college of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39 : 723-31
  26. Weinblatt ME. Rheumatoid arthritis. Lancet 358: 903-911, 2001

Cited by

  1. Reviewing Research on the Study of Rheumatoid Arthritis Model Treated by Pharmacopuncture in Korean Journals Objective vol.25, pp.3, 2015,